Medi-Caps Limited Re-appoints Dharmendra Solanki as Independent Director for Second Term

Medi Caps Limited, a pharmaceutical company based in Indore, has announced the re-appointment of Mr. Dharmendra Solanki as a Non-Executive Independent Director for a second term of five years. The decision, approved by the company's Board of Directors, is subject to shareholder approval at the upcoming 42nd Annual General Meeting.

Key Details of the Re-appointment

• Term: Five years, from February 5, 2026, to February 4, 2031
• Position: Non-Executive Independent Director
• Approval Process: Recommended by the Nomination and Remuneration Committee, approved by the Board, pending shareholder approval

About Dharmendra Solanki

Mr. Solanki brings a wealth of experience to his role at Medi-Caps Limited:

• Education: Bachelor's and Master's degrees in Commerce from Vikram University, Ujjain
• Professional Experience: 27 years of post-qualification experience
• Expertise: Accounts, Finance, and Taxation

Company Statement

Medi-Caps Limited confirmed that Mr. Solanki is not related to any other directors of the company. Additionally, the company stated that he is not debarred from accessing capital markets by SEBI or any other regulatory authority.

Other Board Decisions

In the same board meeting, Medi-Caps Limited also:

1. Approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025.
2. Approved the Board's Report for the year ended March 31, 2025.
3. Scheduled the 42nd Annual General Meeting for September 18, 2025, to be held via video conferencing.
4. Appointed Joshi Sahay and Company as Secretarial Auditor for a five-year term from FY 2025-2026 to FY 2029-2030, subject to shareholder approval.

The re-appointment of Mr. Solanki and these additional decisions reflect Medi-Caps Limited's commitment to maintaining strong corporate governance and ensuring continuity in its board composition.